TGFB1 and pulmonary fibrosis: The preclinical evidence obtained using both mouse fibrotic models, patient‐derived primary lung fibroblasts and IPF lung biopsy samples shows that lncDNM3OS antagonism function not only blocks lung fibrogenesis, but also improves established pulmonary fibrosis; thus, this function may represent a potential TGFβ‐targeted strategy for IPF.63, 64